Reckitt Benckiser has agreed to sell its E45 skincare brand to Swedish pharmaceuticals group Karo Pharma for £200m, the latest disposal of a slower-growing division by the UK consumer group.
The proposed sale of the brand and related products, which generated a combined net sales of £43m as of December 2020, would be another step forward in its plan to “manage its portfolio for higher growth”, the Slough-based group said on Friday.
Reckitt this year sold off most of its Chinese baby formula division Mead Johnson but was forced to write off £8bn of its value. The company had bought the division for £13bn four years ago.
您已阅读46%（625字），剩余54%（740字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。